Controversies in the management of paratesticular rhabdomyosarcoma: Is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma?

Seminars in Pediatric Surgery

Volumn 10, Issue 3, 2001, Pages 146-152

  Wiener, Eugene S ^a   Anderson, James R ^a   Ojimba, Jacqueline I ^a   Lobe, Thomas E ^a   Paidas, Charles ^a   Andrassy, Richard J ^a   Raney, R Beverly ^a   Qualman, Stephen J ^a   Donaldson, Sarah S ^a   Maurer, Harold M ^a   Link, Michael P ^a   Crist, William M ^a   Grier, Holcombe E ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ADOLESCENCE; ADOLESCENT; ARTICLE; CANCER STAGING; CHILD; COMPUTER ASSISTED TOMOGRAPHY; HIGH RISK POPULATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SURVIVAL RATE; TESTIS CANCER; TREATMENT OUTCOME;

EID: 0034907053     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/spsu.2001.24695     Document Type: Article

References (16)

1. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma
2. Biology and therapy of pediatric: Rhabdomyosarcoma
3. Radiation to regional nodes for rhabdomyosarcoma of the genitourinary tract in children: Is it necessary?
4. Rhabdomyosarcoma involving the genitourinary organs retroperitoneum and pelvis
5. The Third Intergroup Rhabdomyosarcoma Study (IRS)
6. Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcoma
7. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: Results from the Intergroup Rhabdomyosarcoma Study IV
8. Late effects of therapy with paratesticular rhabdomyosarcoma
9. The management of paratesticular rhabdomyosarcoma: A single institutional experience with 44 consecutive children
10. Reduced gonodal toxicity after I.V. cyclophosphamide administration in patients with non-malignant disease
11. Small testicles with impaired production of sperm in adult male survivors of childhood malignancies
12. Testicular dysfunction after cyclophosphamide-vincritine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study
13. Male fertility in long-term survivors of childhood acute lymphoblastic leukemia
14. Gonodal function in young patients successfully treated for Hodgkin disease
15. Association of cyclophosphamide-induced male-mediated, foetal abnormalities with reduced paternal germ-cell apoptosis